{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Berberine", "cancer therapy", "natural products", "oncology", "phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32735398", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "31"}], "Language": ["eng"], "ELocationID": ["10.1002/iub.2350"], "Journal": {"ISSN": "1521-6551", "JournalIssue": {"Volume": "72", "Issue": "10", "PubDate": {"Year": "2020", "Month": "Oct"}}, "Title": "IUBMB life", "ISOAbbreviation": "IUBMB Life"}, "ArticleTitle": "Berberine: A novel therapeutic strategy for cancer.", "Pagination": {"StartPage": "2065", "EndPage": "2079", "MedlinePgn": "2065-2079"}, "Abstract": {"AbstractText": ["Cancer, even currently, is one of the main reasons for mortality and morbidity, worldwide. In recent years, a great deal of effort has been made to find efficient therapeutic strategies for cancer, however, particularly with regards to side effects and the possibility of complete remission. Berberine (BBR) is a nature-driven phytochemical component originated from different plant groups such as Berberis vulgaris, Berberis aquifolium, and Berberis aristata. BBR is a well-known nutraceutical because of its wide range of pharmacological activities including anti-inflammatory, antidiabetic, antibacterial, antiparasitic, antidiarrheal, antihypertensive, hypolipidemic, and fungicide. In addition, it exhibits inhibitory effects on multiple types of cancers. In this review, we have elaborated on the anticancer effects of BBR through the regulation of different molecular pathways such as: inducing apoptosis, autophagy, arresting cell cycle, and inhibiting metastasis and invasion."], "CopyrightInformation": "\u00a9 2020 International Union of Biochemistry and Molecular Biology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Samadi", "ForeName": "Parisa", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Sarvarian", "ForeName": "Parisa", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Gholipour", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hematology Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Asenjan", "ForeName": "Karim Shams", "Initials": "KS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Aghebati-Maleki", "ForeName": "Leili", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Motavalli", "ForeName": "Roza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immune and Gene Therapy Lab, Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden."}], "LastName": "Hojjat-Farsangi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0003-0099-6728"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}, {"Identifier": [], "Affiliation": "Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Yousefi", "ForeName": "Mehdi", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "IUBMB Life", "NlmUniqueID": "100888706", "ISSNLinking": "1521-6543"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Autophagy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": ["chemistry"], "DescriptorName": "Berberis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chabner BA, Roberts TG Jr. Chemotherapy and the war on cancer. Nat Rev Cancer. 2005;5(1):65-72."}, {"Citation": "International Agency for Research on Cancer 2019. Available from: http://gco.iarc.fr/."}, {"Citation": "Khan MSA, Ahmad I. Herbal medicine: Current trends and future prospects. New look to phytomedicine. Cambridge, Massachusetts: Elsevier, 2019; p. 3-13."}, {"Citation": "El Sayed M, Ghareeb D, Sarhan E, Khalil A. Therapeutic bio-screening of the bioactive ingredients of Berberis vulgaris. Funct Plant Sci Biotechnol. 2011;5(1):63-68."}, {"Citation": "Wang W-J, Zhang T. Integration of traditional Chinese medicine and Western medicine in the era of precision medicine. J Integr Med. 2017;15(1):1-7.http://dx.doi.org/10.1016/s2095-4964(17)60314-5."}, {"Citation": "Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015;33(8):1582-1614."}, {"Citation": "Dutta S, Mahalanobish S, Saha S, Ghosh S, Sil PC. Natural products: An upcoming therapeutic approach to cancer. Food Chem Toxicol. 2019;128:240-255."}, {"Citation": "Wang S, Long S, Wu W. Application of traditional Chinese medicines as personalized therapy in human cancers. Am J Chin Med. 2018;46(5):953-970."}, {"Citation": "Khazir J, Mir BA, Pilcher L, Riley DL. Role of plants in anticancer drug discovery. Phytochem Lett. 2014;7:173-181."}, {"Citation": "Herbals C. Board, the State Administrative Bureau of Chinese Medicine of China. Chinese Herbals (\u4e2d\u534e\u672c\u8349). 1999;6:525-544."}, {"Citation": "Habtemariam S. Recent advances in Berberine inspired anticancer approaches: From drug combination to novel formulation technology and derivatization. Molecules. 2020;25(6):1426."}, {"Citation": "Chen F, Gao X. Huanglian-containing prescriptions and dispesations in ancient Chinese literatures. Chin Trad Pat Med. 1997;19:40-41."}, {"Citation": "Xu J, Wang L, Xu B. Research development of Coptis chinensis. Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae. 2004;26(6):704-707."}, {"Citation": "Abd El-Wahab Abeer E, Ghareeb Doaa A, Sarhan Eman EM, Abu-Serie Marwa M, El Demellawy Maha A. In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med. 2013;13:1. http://dx.doi.org/10.1186/1472-6882-13-218."}, {"Citation": "Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22:(8):999-1012. http://dx.doi.org/10.1002/ptr.2399."}, {"Citation": "Amin A, Subbaiah T, Abbasi K. Berberine sulfate: Antimicrobial activity, bioassay, and mode of action. Can J Microbiol. 1969;15(9):1067-1076."}, {"Citation": "Khin-Maung-U M-K, Nyunt-Nyunt-Wai A-K. Clinical trial of Berberine in acute watery diarrhoea. Br Med J (Clin Res Ed). 1985;291(6509):1601-1605."}, {"Citation": "Rabbani GH, Butler T, Knight J, Sanyal S, Alam K. Randomized controlled trial of Berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis. 1987;155(5):979-984."}, {"Citation": "Dutta N, Panse M. Usefulness of Berberine (an Alkaloid from Berberis aristata) in the treatment of cholera (experimental). Indian J Med Res. 1962;50(5):732-736."}, {"Citation": "Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol. 2009;126(1):5-17."}, {"Citation": "Iizuka N, Miyamoto K, Hazama S, et al. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett. 2000;158(1):35-41."}, {"Citation": "Kuo C-L, Chi C-W, Liu T-Y. The anti-inflammatory potential of Berberine in vitro and in vivo. Cancer Lett. 2004;203(2):127-137."}, {"Citation": "Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet. 2001;357(9255):539-545."}, {"Citation": "Liao H, Yang Y, Bai J. A survey of therapeutic and adjunctional effects of Chinese medicines on tumours. Xi Zang Ke Ji. 2003;8:42-43."}, {"Citation": "Guam\u00e1n Ortiz L, Lombardi P, Tillhon M, Scovassi A. Berberine, an epiphany against cancer. Molecules. 2014;19(8):12349-12367."}, {"Citation": "Li J, Liu F, Jiang S, et al. Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways. Oncol Lett. 2018;15(5):7409-7414."}, {"Citation": "Liu L, Fan J, Ai G, et al. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol Res. 2019;52(1):37."}, {"Citation": "Wang K, Zhang C, Bao J, et al. Synergistic chemopreventive effects of curcumin and Berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep. 2016;6:26064."}, {"Citation": "Dai B, Ma Y, Yang T, et al. Synergistic effect of Berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma. Phytother Res. 2019;33(3):745-755."}, {"Citation": "Gilman A. Therapeutic applications of chemical warfare agents. Fed Proc. 1946;5:285-292."}, {"Citation": "Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med. 1948;238(23):787-793."}, {"Citation": "Li MC, Hertz R, Bergenstal DM. Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. N Engl J Med. 1958;259(2):66-74."}, {"Citation": "Johnson IS, Armstrong JG, Gorman M, Burnett JP Jr. The vinca alkaloids: A new class of oncolytic agents. Cancer Res. 1963;23:1390-1427."}, {"Citation": "Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1912-1934."}, {"Citation": "Arruebo M, Vilaboa N, Saez-Gutierrez B, et al. Assessment of the evolution of cancer treatment therapies. Cancer. 2011;3(3):3279-3330."}, {"Citation": "Phillips EH, Franklin M, Carroll BJ, Fallas MJ, Ramos R, Rosenthal D. Laparoscopic colectomy. Ann Surg. 1992;216(6):703-707."}, {"Citation": "Sherwood JT, Brock MV. Lung cancer: New surgical approaches. Respirology (Carlton, Vic). 2007;12(3):326-332."}, {"Citation": "Gullotti E, Yeo Y. Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery. Mol Pharm. 2009;6(4):1041-1051."}, {"Citation": "Brand K. Gene and cell therapy: Therapeutic mechanisms and strategies. Chapter. 2005;36:760-799."}, {"Citation": "Prakash O, Kumar A, Kumar P. Anticancer potential of plants and natural products. Am J Pharmacol Sci. 2013;1:104-115."}, {"Citation": "Efferth T, Li PC, Konkimalla VSB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007;13(8):353-361."}, {"Citation": "Kawano M, Takagi R, Kaneko A, Matsushita S. Berberine is a dopamine D1-and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses. J Neuroimmunol. 2015;289:43-55."}, {"Citation": "Li H, Li XL, Zhang M, et al. Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity. Scand J Immunol. 2014;79(1):12-19."}, {"Citation": "Yang Y, Qi J, Wang Q, et al. Berberine suppresses Th17 and dendritic cell responses. Invest Ophthalmol Vis Sci. 2013;54(4):2516-2522."}, {"Citation": "Wang YX, Pang WQ, Zeng QX, et al. Synthesis and biological evaluation of new Berberine derivatives as cancer immunotherapy agents through targeting IDO1. Eur J Med Chem. 2018;143:1858-1868."}, {"Citation": "Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S. Physicochemical characterization of Berberine chloride: A perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech. 2010;11(3):1466-1475."}, {"Citation": "Singh IP, Mahajan S. Berberine and its derivatives: A patent review (2009-2012). Expert Opin Ther Pat. 2013;23(2):215-231."}, {"Citation": "Srivastava S, Srivastava M, Misra A, Pandey G, Rawat A. A review on biological and chemical diversity in Berberis (Berberidaceae). EXCLI J. 2015;14:247."}, {"Citation": "Godugu C, Patel AR, Doddapaneni R, Somagoni J, Singh M. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PLoS One. 2014;9(3):e89919."}, {"Citation": "Imenshahidi M, Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. 2019;33(3):504-523."}, {"Citation": "Spinozzi S, Colliva C, Camborata C, et al. Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects. J Nat Prod. 2014;77(4):766-772."}, {"Citation": "Liu Y-T, Hao H-P, Xie H-G, et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos. 2010;38(10):1779-1784."}, {"Citation": "Ayati SH, Fazeli B, Momtazi-Borojeni AA, Cicero AF, Pirro M, Sahebkar A. Regulatory effects of berberine on microRNome in cancer and other conditions. Crit Rev Oncol Hematol. 2017;116:147-158."}, {"Citation": "Mirhadi E, Rezaee M, Malaekeh-Nikouei B. Nano strategies for berberine delivery, a natural alkaloid of Berberis. Biomed Pharmacother. 2018;104:465-473."}, {"Citation": "Habtemariam S. Berberine and inflammatory bowel disease: A concise review. Pharmacol Res. 2016;113:592-599."}, {"Citation": "Cicero AF, Baggioni A. Berberine and its role in chronic disease. Anti-inflammatory nutraceuticals and chronic diseases. New York: Springer, 2016; p. 27-45."}, {"Citation": "Shinjyo N, Parkinson J, Bell J, Katsuno T, Bligh A. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. J Integ Med. 2020;18(2):125-151."}, {"Citation": "Liang Y, Xu X, Yin M, et al. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: A systematic literature review and a meta-analysis. Endocr J. 2019;66(1):51-63."}, {"Citation": "Jamshaid F, Dai J, Yang LX. New development of novel berberine derivatives against bacteria. Mini Rev Med Chem. 2020;20(8):716-724."}, {"Citation": "Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci. 2017;20(5):557-568."}, {"Citation": "Jin X, Song X, Cao Y, Jiang Y, Sun Q. Research progress in structural modification and pharmacological activities of berberine. J Pharm Pract. 2014;32:171-175."}, {"Citation": "Zhou Y, Liu S-Q, Yu L, et al. Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling. Apoptosis. 2015;20(9):1187-1199."}, {"Citation": "Jeong HW, Hsu KC, Lee J-W, et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol-Endocrinol Metab. 2009;296(4):E955-E964."}, {"Citation": "Li Z, Jiang T, Lu Q, et al. Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells. Cell Mol Neurobiol. 2019;40(4):1-16."}, {"Citation": "Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100."}, {"Citation": "Li H, Feng C, Fan C, et al. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. Cell Death Dis. 2020;11(4):1-17."}, {"Citation": "Dkhil MA, Metwaly MS, Al-Quraishy S. Berberine improves the intestinal antioxidant status of laboratory mice, Mus musculus. Saudi J Biol Sci. 2017;24(7):1567-1573."}, {"Citation": "Kim J-H, Ryu A-R, Kang M-J, Lee M-Y. Berberine-induced changes in protein expression and antioxidant enzymes in melanoma cells. Mol Cellular Toxicol. 2016;12(1):53-61."}, {"Citation": "Yao M, Fan X, Yuan B, et al. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement Altern Med. 2019;19(1):216."}, {"Citation": "Qin Q-P, Wang Z-F, Huang X-L, et al. Two telomerase-targeting Pt(II) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells. Dalton Trans. 2019;48(40):15247-15254."}, {"Citation": "Luo Y, Tian G, Zhuang Z, et al. Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. Am J Translat Res. 2019;11(5):2668-2682."}, {"Citation": "Liu Y, Hua W, Li Y, et al. Berberine suppresses colon cancer cell proliferation by inhibiting the scap/srebp-1 signaling pathway-mediated lipogenesis. Biochem Pharmacol. 2020;174:113776."}, {"Citation": "Tillhon M, Ortiz LMG, Lombardi P, Scovassi AI. Berberine: New perspectives for old remedies. Biochem Pharmacol. 2012;84(10):1260-1267."}, {"Citation": "Hamsa T, Kuttan G. Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells. Phytother Res. 2012;26(4):568-578."}, {"Citation": "Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med. 2007;13(12):535-541."}, {"Citation": "Ulukaya E, Acilan C, Yilmaz Y. Apoptosis: Why and how does it occur in biology? Cell Biochem Funct. 2011;29(6):468-480."}, {"Citation": "Hockenbery D, Nu\u00f1ez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348(6299):334-336."}, {"Citation": "Zapata JM, Pawlowski K, Haas E, Ware CF, Godzik A, Reed JC. A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem. 2001;276(26):24242-24252."}, {"Citation": "Fulda S, Debatin K-M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25(34):4798-4811."}, {"Citation": "Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281(5381):1309-1312."}, {"Citation": "Knudson CM, Brown NM. Mitochondria potential, bax \u201cactivation,\u201d and programmed cell death. Apoptosis and cancer. Totowa, New Jersey: Springer, 2008; p. 95-108."}, {"Citation": "Zhao Y, Jing Z, Lv J, et al. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo. Biomed Pharmacother. 2017;95:18-24."}, {"Citation": "Wang N, Feng Y, Zhu M, et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism. J Cell Biochem. 2010;111(6):1426-1436."}, {"Citation": "Ma X, Zhou J, Zhang C-X, et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. 2013;34(18):4452-4465."}, {"Citation": "Kim J-S, Oh D, Yim M-J, et al. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells. Oncol Rep. 2015;33(4):1775-1782."}, {"Citation": "Agnarelli A, Natali M, Garcia-Gil M, et al. Cell-specific pattern of berberine pleiotropic effects on different human cell lines. Sci Rep. 2018;8(1):10599."}, {"Citation": "Yao Z, Wan Y, Li B, et al. Berberine induces mitochondrial-mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI-H2452 cells. Oncol Rep. 2018;40(6):3603-3610."}, {"Citation": "Lin C-C, Kao S-T, Chen G-W, Ho H-C, Chung J-G. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res. 2006;26(1A):227-242."}, {"Citation": "Hu H-y, Li K-P, Wang X-J, et al. Set9, NF-\u03baB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol Sin. 2013;34(1):157-166."}, {"Citation": "Okubo S, Uto T, Goto A, et al. Berberine induces apoptotic cell death via activation of caspase-3 and-8 in HL-60 human leukemia cells: Nuclear localization and structure-activity relationships. Am J Chin Med. 2017;45(7):1497-1511."}, {"Citation": "Schafer K. The cell cycle: A review. Vet Pathol. 1998;35(6):461-478."}, {"Citation": "Malumbres M, Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci. 2005;30(11):630-641."}, {"Citation": "S\u00e1nchez I, Dynlacht BD, editors. New insights into cyclins, CDKs, and cell cycle control. Seminars in cell & developmental biology. United States: Elsevier, 2005."}, {"Citation": "Cai C, Huang W, Zhou J, et al. An insight into the molecular mechanism of berberine towards multiple cancer types through systems pharmacology. Front Pharmacol. 2019;10:857."}, {"Citation": "Cai Y, Xia Q, Luo R, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014;68(1):53-62."}, {"Citation": "Sha S, Zhang Y, Xu B, Wang H, Kong X, Wu K. Effect of berberine on cell proliferation and apoptosis in gastric carcinoma cells. Modern Oncol. 2011;19:629-633."}, {"Citation": "Liu Z, Liu Q, Xu B, et al. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res/Fundamental Mol Mechan Mutagen. 2009;662(1-2):75-83."}, {"Citation": "Eo S-H, Kim J-H, Kim S-J. Induction of G2/M arrest by berberine via activation of PI3K/Akt and p38 in human chondrosarcoma cell line. Oncol Res Featu Preclin Clin Cancer Therap. 2015;22(3):147-157."}, {"Citation": "Zhao Y, Hou J, Mi P, et al. Exo70 is transcriptionally up-regulated by hepatic nuclear factor 4\u03b1 and contributes to cell cycle control in hepatoma cells. Oncotarget. 2016;7(8):9150-9162."}, {"Citation": "Chu Q, Jiang Y, Zhang W, et al. Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma. Oncotarget. 2016;7(51):84658-84665."}, {"Citation": "Hu S, Chen C-W, Chen S-T, et al. Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells. Int Immunopharmacol. 2019;66:267-273."}, {"Citation": "Wang J, Qi Q, Feng Z, et al. Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway. Oncotarget. 2016;7(41):66944-66958."}, {"Citation": "Jantov\u00e1 S, Lu \u010c, \u010cer\u0148\u00e1kov\u00e1 M, Ko\u0161t \u00c1lov\u00e1 D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol. 2003;55(8):1143-1149."}, {"Citation": "Hsieh Y-C, Athar M, Chaudry IH. When apoptosis meets autophagy: Deciding cell fate after trauma and sepsis. Trends Mol Med. 2009;15(3):129-138."}, {"Citation": "Gao M, Yeh PY, Lu Y-S, et al. OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Cancer Res. 2008;68(22):9348-9357."}, {"Citation": "La X, Zhang L, Li Z, Yang P, Wang Y. Berberine-induced autophagic cell death by elevating GRP78 levels in cancer cells. Oncotarget. 2017;8(13):20909-20924."}, {"Citation": "Liu J, Zhu Z, Liu Y, et al. MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of berberine in p53-null leukemic cells. Life Sci. 2020;242:117228."}, {"Citation": "Zhang Q, Wang X, Cao S, et al. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Biomed Pharmacother. 2020;128:110245."}, {"Citation": "Liu J, Liu P, Xu T, et al. Berberine induces autophagic cell death in acute lymphoblastic leukemia by inactivating AKT/mTORC1 signaling. Drug Des Devel Ther. 2020;14:1813."}, {"Citation": "Jia Z, Lin L, Huang S, Zhu Z, Huang W, Huang Z. Inhibition of autophagy by berberine enhances the survival of H9C2 myocytes following hypoxia. Mol Med Rep. 2017;16(2):1677-1684."}, {"Citation": "Domitrovi\u0107 R, Cvijanovi\u0107 O, Pernjak-Pugel E, \u0160koda M, Mikeli\u0107 L, Crn\u010devi\u0107-Orli\u0107 \u017d. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol. 2013;62:397-406."}, {"Citation": "Wang Y, Liu Y, Du X, Ma H, Yao J. Berberine reverses doxorubicin resistance by inhibiting autophagy through the PTEN/Akt/mTOR signaling pathway in breast Cancer. Onco Targets Ther. 2020;13:1909-1919."}, {"Citation": "Mohammadinejad R, Ahmadi Z, Tavakol S, Ashrafizadeh M. Berberine as a potential autophagy modulator. J Cell Physiol. 2019;234(9):14914-14926."}, {"Citation": "Liu PL, Tsai JR, Charles AL, et al. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res. 2010;54(suppl 2):S196-S204."}, {"Citation": "Huang J-F, Du W-X, Chen J-J. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis. J BUON. 2016;21(1):235-243."}, {"Citation": "Ho Y-T, Lu C-C, Yang J-S, et al. Berberine induced apoptosis via promoting the expression of caspase-8,-9 and-3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 2009;29(10):4063-4070."}, {"Citation": "Kim H-S, Kim M-J, Kim EJ, Yang Y, Lee M-S, Lim J-S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol. 2012;83(3):385-394."}, {"Citation": "Hu Q, Li L, Zou X, Xu L, Yi P. Berberine attenuated proliferation, invasion and migration by targeting the AMPK/HNF4alpha/WNT5A pathway in gastric carcinoma. Front Pharmacol. 2018;9:1150."}, {"Citation": "Wu CM, Li TM, Tan TW, Fong YC, Tang CH. Berberine reduces the metastasis of Chondrosarcoma by modulating the alpha v beta 3 integrin and the PKC delta, c-Src, and AP-1 signaling pathways. Evid Based Complement Alternat Med. 2013;2013:423164."}, {"Citation": "Liu CH, Tang WC, Sia P, et al. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. Int J Med Sci. 2015;12(1):63-71."}, {"Citation": "Liu X, Ji Q, Ye N, et al. Berberine inhibits invasion and metastasis of colorectal Cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway. PLoS One. 2015;10(5):e0123478."}, {"Citation": "Liu J-F, Lai K, Peng S-F, et al. Berberine inhibits human melanoma A375. S2 cell migration and invasion via affecting the FAK, uPA, and NF-\u03baB signaling pathways and inhibits PLX4032 resistant A375. S2 cell migration in vitro. Molecules. 2018;23(8):2019."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "6", "Day": "2"}, {"Year": "2020", "Month": "6", "Day": "28"}, {"Year": "2020", "Month": "6", "Day": "29"}, {"Year": "2020", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32735398", "10.1002/iub.2350"]}}], "PubmedBookArticle": []}